Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application

RecruitingOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

February 24, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Hernia, VentralHernia IncisionalHernia Incisional Ventral
Interventions
DEVICE

Hernia repair with mesh

Hernia repair with GORE® SYNECOR Biomaterial; technical approach laparoscopic, robotic or open surgical / minimally invasive surgery

Trial Locations (15)

11794

ACTIVE_NOT_RECRUITING

Stony Brook University Hospital, Stony Brook

23116

ACTIVE_NOT_RECRUITING

Bon Secours Memorial Regional Medical Center, Mechanicsville

28401

ACTIVE_NOT_RECRUITING

Novant Health New Hanover Regional Medical Center, Wilmington

29605

ACTIVE_NOT_RECRUITING

Prisma Health Greenville Memorial Hospital, Greenville

30342

ACTIVE_NOT_RECRUITING

Emory Saint Joseph's Hospital, Atlanta

41009

RECRUITING

University Hospital Virgen Macarena - Department of General And Digestive Surgery, Seville

41013

RECRUITING

Hospital Quirón Salud-Sagrado Corazón, Seville

41126

RECRUITING

Ospedale Civile di Baggiovara, Baggiovara

49506

ACTIVE_NOT_RECRUITING

Corewell Health, Grand Rapids

80131

RECRUITING

Vincenzo Monaldi Hospital, Napoli

87109

ACTIVE_NOT_RECRUITING

Lovelace Women's Hospital, Albuquerque

02111

ACTIVE_NOT_RECRUITING

Tufts Medical Center, Boston

00189

RECRUITING

Sapienza Università di Roma, Roma

B15 2GW

RECRUITING

University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham, Birmingham

WS2 9PS

RECRUITING

Walsall Manor Hospital, Walsall

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY